Aptadel Therapeutics

We'll be exhibiting next 22-25 Oct, 2024 at the World Orphan Drug Congress in #Barcelona. Do not miss the opportunity to book a meeting and talk to the team, Adrian Gabriel Torres PhD and Nadia Pons will be happy to discuss more about Aptadel's next developments for rare diseases. #RNAtherapeutics #RNAaptamers #aptamerdrugconjugates #paediatriconcology #orphandrug #rarediseases #ewingsarcoma

🏆 We are happy to announce that Aptadel Therapuetics has won the best pitch award at the EIT Health Spain final for the Catapult program. 👏 Thanks to the organisaton team, Antonio Rodríguez Hita, for such a fantastic event and to the jury for their feedback. Cinta Díez, PhD César Velasco Muñoz Javier Colás Fustero and Sergio San Agustín Gisela Lorente

📢 Our CEO, Gisela Lorente, will be pitching next Oct 9th at the EIT Health's Catapult competition. 🤝 Join us and learn more about how Aptadel's RNA platform will transform the treatment of childhood cancer. EIT Health EIT Health Spain

📢 We are excited to share the publication of our latest paper, “The future of aptamers in cancer diagnosis, prognosis and treatment ", in Expert Opinion on Biological Therapy. This work highlights the most exciting applications of #aptamer technologies in #oncology and offers a critical overview on what is needed to bring them closer to patients. Aptadel Therapeutics is proud to contribute to this endeavour by continuously pushing the boundaries of innovation in aptamer technologies for the treatment of childhood cancer. 🔗 Check out the full article: https://lnkd.in/dpYhw38f #RNAtherapeutics #aptamersdrugconjugates #oncology #biotech #innovation #scientificResearch #healthcare #barcelona Jazmine Arévalo Adrian Gabriel Torres PhD

📣 [ENG] Aptadel Therapeutics has been highlighted as one of the five startups to follow-up in the field of #oncology this 2024, according to the StartUs Insights report. 👉🏻 Read the full article: https://lnkd.in/dB4wywqi [ESP] Aptadel Therapeutics es una de las cinco startups destacadas en el campo de la #oncología para 2024, según el informe de StartUs Insights. Lee la noticia completa: https://lnkd.in/dB4wywqi #starup #oncology #RNAtherapeutics #ewingsarcoma #barcelonahealthecosystem #health #cuttingedgescience

Aptadel Therapeutics is one of the finalists bioetchs at the #RESI Innovation Pitch Challenge. Our CEO, Gisela Lorente will be pitching. Very exciting!!

🔔 Do not miss the opportunity to book a meeting with our COO, Nadia Pons, next week at #BioSpringEurope #RNAtherapeutics #oncology #Barcelona #healthstartup

🚀 Are you a laboratory technician with experience in animal experimentation in oncology? Apdatel is #hiring! Join our passionate team and participate in the development of new cancer treatments, based on RNA technologies. Help us improve pediatric oncology patients’ lives. Apply now 👇 #jobopportunity #healthstartup #laboratorytechnician #Barcelona #oncology

🚀 Are you a PhD with experience in animal experimentation in oncology? Apdatel is #hiring! Join our passionate team and participate in the development of new cancer treatments, based on RNA technologies. Help us improve pediatric oncology patients’ lives. Apply now 👇 #jobopportunity #healthstartup #PhD #Barcelona #oncology

📣 Our Head of R+D, Adrian Gabriel Torres PhD, will be participating in the #Biologics24Congress. Don't miss the change to meet him and learn about Aptadel's latest developments. #RNAtherapeutics #oncology #drugdevelopment #healthstartup